It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The COVID-19 pandemic has highlighted the need for FAIR (Findable, Accessible, Interoperable, and Reusable) data more than any other scientific challenge to date. We developed a flexible, multi-level, domain-agnostic FAIRification framework, providing practical guidance to improve the FAIRness for both existing and future clinical and molecular datasets. We validated the framework in collaboration with several major public-private partnership projects, demonstrating and delivering improvements across all aspects of FAIR and across a variety of datasets and their contexts. We therefore managed to establish the reproducibility and far-reaching applicability of our approach to FAIRification tasks.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details























1 University of Luxembourg, Luxembourg Centre for Systems Biomedicine, ELIXIR Luxembourg, Belval, Luxembourg (GRID:grid.16008.3f) (ISNI:0000 0001 2295 9843)
2 The University of Manchester, University of Manchester, Department of Computer Science, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
3 University of Oxford, Oxford e-Research Centre, Department of Engineering Science, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
4 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726)
5 Bayer AG, Business Development & Licensing & OI, Berlin, Germany (GRID:grid.420044.6) (ISNI:0000 0004 0374 4101)
6 The Hyve BV, Utrecht, The Netherlands (GRID:grid.511638.8)
7 Bayer AG, Business Development & Licensing & OI, Berlin, Germany (GRID:grid.420044.6) (ISNI:0000 0004 0374 4101); Institute for Globally Distributed Open Research and Education (IGDORE), Gothenburg, Sweden (GRID:grid.499279.8)
8 Imperial College, Data Science Institute, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
9 Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) and Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), Schnackenburgallee 114, Frankfurt, Germany (GRID:grid.510864.e)
10 Maastricht University, Department of Bioinformatics (BiGCaT), NUTRIM, FHML, Maastricht, The Netherlands (GRID:grid.5012.6) (ISNI:0000 0001 0481 6099)
11 Umm Al-Qura University, College of Computer and Information Systems, Mecca, Saudi Arabia (GRID:grid.412832.e) (ISNI:0000 0000 9137 6644)
12 Heriot-Watt University, Department of Computer Science, Edinburgh, UK (GRID:grid.9531.e) (ISNI:0000000106567444)
13 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK (GRID:grid.225360.0) (ISNI:0000 0000 9709 7726); 661 University Avenue, Ontario Institute for Cancer Research MaRS Centre, Toronto, Canada (GRID:grid.419890.d) (ISNI:0000 0004 0626 690X)
14 Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006)
15 Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland (GRID:grid.419481.1) (ISNI:0000 0001 1515 9979)
16 OpenPhacts Foundation, Cambridge, UK (GRID:grid.419481.1)
17 Foundation Lygature, Utrecht, Netherlands (GRID:grid.491493.2)